CRWV

CoreWeave, Inc. Class A Common Stock

52
Fundamentals43/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential42/ 100

CRWV offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

NKE

NIKE, Inc.

60
Fundamentals56/ 100
Valuation80/ 100
Upside potential58/ 100
Risk potential18/ 100

NKE has the edge over CRWV overall, supported by stronger valuation and lower modeled downside.

CRWV Fundamentals

MetricStatus
Strong
Under pressure
Weak
Strong

CRWV's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.

NKE Fundamentals

MetricStatus
Stable
Healthy
Stable
Strong

NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.

CRWV PE Valuation

CRWV has no meaningful PE right now: it lost money over the past year.

NKE PE Valuation

CHEAPFAIREXPENSIVE21x43x64x86x
CHEAPFAIREXPENSIVE21x43x64x86x
LevelPEPriceVs current
Current18x$37.76—
Cheap23x$47.70+26%
Forward30x$37.76—
Fair33x$68.16+80%
Expensive47x$97.86+159%

Historical ranges are pointers, not guarantees.

NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.

CRWV Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Moderate
Low

CRWV has the edge over NKE on the outlook, with more favorable earnings and revenue expectations.

NKE Forward outlook

MetricOutlook
Strongly deteriorating
Stable
Decline
Improving
Moderate
Low

Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.

CRWV Risk to reward

ScenarioChangePrice
Upside+79%$101.48
Downside-42%$32.77

Calculated from the latest close: $56.60 on Nov 12.

CRWV has a better modeled risk to reward balance than NKE, with more potential upside relative to its potential downside.

NKE Risk to reward

ScenarioChangePrice
Upside+25%$47.36
Downside-18%$30.83

Calculated from the latest close: $37.76 on Nov 12.

NKE trails CRWV on modeled risk to reward, with less potential upside relative to its potential downside.

CRWV Earnings Per Share

Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
QuarterTTM EPSYoY
Q3 2026-$4.31-$1.83
Q2 2026-$3.26-$0.16
Q1 2026-$2.72+$0.62
Q4 2025-$2.81-$0.64
Q3 2025-$2.48-$0.06

CRWV lost $4.31 per share over the past year, a bigger loss than the year before.

NKE Earnings Per Share

Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
Q4 2023: $3.42Q1 2024: $3.40Q2 2024: $3.73Q3 2024: $3.49Q4 2024: $3.24Q1 2025: $3.01Q2 2025: $2.16Q3 2025: $1.95Q4 2025: $1.70Q1 2026: $1.51Q2 2026: $2.10Q3 2026: $2.09Forward: $1.27
QuarterTTM EPSYoY
Forward$1.27-39%
Q3 2026$2.09+7.2%
Q2 2026$2.10-2.8%
Q1 2026$1.51-50%
Q4 2025$1.70-48%
Q3 2025$1.95-44%
Q2 2025$2.16-42%
Q1 2025$3.01-11%
Q4 2024$3.24-5.3%

NKE has the edge over CRWV on earnings quality, reporting a profit while its opponent remains loss making.

CRWV Quarterly Revenue

Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
QuarterRevenueYoY
Q3 2026$3.7B+168%
Q2 2026$2.6B+112%
Q1 2026$2.1B+112%
Q4 2025$1.6B+110%
Q3 2025$1.4B+134%
Q2 2025$1.2B+207%
Q1 2025$981.6M+420%
Q4 2024$747.4M+544%

CRWV has the edge over NKE on sales, with more consistent year-over-year improvement.

NKE Quarterly Revenue

Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
Q4 2023: $13.4BQ1 2024: $12.4BQ2 2024: $12.6BQ3 2024: $11.6BQ4 2024: $12.4BQ1 2025: $11.3BQ2 2025: $11.1BQ3 2025: $11.7BQ4 2025: $12.4BQ1 2026: $11.3BQ2 2026: $11BQ3 2026: $11.2B
QuarterRevenueYoY
Q3 2026$11.2B-4.3%
Q2 2026$11B-1.1%
Q1 2026$11.3B+0.1%
Q4 2025$12.4B+0.6%
Q3 2025$11.7B+1.1%
Q2 2025$11.1B-12%
Q1 2025$11.3B-9.3%
Q4 2024$12.4B-7.7%

NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.

CRWV Free Cash Flow

Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
QuarterFree cash flowYoY
Q3 2026-$7.5B-$6.8B
Q2 2026-$5.7B-$3B
Q1 2026-$4.7B-$3.4B
Q4 2025-$2.5B+$810.3M
Q3 2025-$699.8M-$125.8M
Q2 2025-$2.7B-$339.3M
Q1 2025-$1.3B-553%
Q4 2024-$3.3B-$2.2B

CRWV has burned cash in almost every quarter: −$20.4B over the past year, against −$8.1B the year before.

NKE Free Cash Flow

Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
Q4 2023: $2.6BQ1 2024: $1.9BQ2 2024: $2.4BQ3 2024: $274MQ4 2024: $920MQ1 2025: $1.7BQ2 2025: $363MQ3 2025: $15MQ4 2025: $386MQ1 2026: $284MQ2 2026: $1.5BQ3 2026: −$64M
QuarterFree cash flowYoY
Q3 2026-$64M-527%
Q2 2026$1.5B+313%
Q1 2026$284M-83%
Q4 2025$386M-58%
Q3 2025$15M-95%
Q2 2025$363M-85%
Q1 2025$1.7B-11%
Q4 2024$920M-65%

NKE has the edge over CRWV on cash generation, producing positive trailing cash flow while its opponent burns cash.

CRWV Total Shares

Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
PeriodChange %Net change
Quarterly+1.5%+8M shares
1 year+12%+61.1M shares

CRWV has 559M diluted shares, up 12% from a year ago.

NKE Total Shares

Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
Q4 2023: 1.5BQ1 2024: 1.5BQ2 2024: 1.5BQ3 2024: 1.5BQ4 2024: 1.5BQ1 2025: 1.5BQ2 2025: 1.5BQ3 2025: 1.5BQ4 2025: 1.5BQ1 2026: 1.5BQ2 2026: 1.5BQ3 2026: 1.5B
PeriodChange %Net change
Quarterly+0.2%+3.2M shares
1 year+0.4%+5.2M shares
3 years-3.8%-59.1M shares
5 years-8.4%-135M shares
Available history-6.9%-110M shares

NKE has the edge over CRWV on shareholder dilution, with a more favorable share count trend.

CRWV Net Leverage

Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
QuarterNet LeverageStatus
Q3 2026-0.8xNet Cash
Q2 2026-1.5xNet Cash
Q1 20267.6xHigh
Q4 20257.6xHigh
Q3 20255.6xHigh
Q2 20256.5xHigh
Q1 20258.4xHigh
Q4 202419.3xHigh

CRWV has the edge over NKE on leverage, with a lower net debt burden relative to earnings.

NKE Net Leverage

Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
Q4 2023: 0.1xQ1 2024: -0.0xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.2xQ1 2025: 0.1xQ2 2026: 0.1xQ3 2026: 0.2x
QuarterNet LeverageStatus
Q3 20260.2xVery low
Q2 20260.1xVery low
Q1 20250.1xVery low
Q4 20240.2xVery low
Q3 20240.1xVery low
Q2 2024-0.1xNet Cash
Q1 2024-0.0xVery low
Q4 20230.1xVery low

NKE's net debt is less than a year of its operating earnings (EBITDA).

CRWV Weekly Momentum

MetricValueStatus
RSI39.7Neutral
Stochastic11.3Oversold

CRWV's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).

NKE Weekly Momentum

MetricValueStatus
RSI40.0Neutral
Stochastic57.5Neutral

NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).

CRWV PE vs Technology Sector

CRWV has no meaningful PE right now: it lost money over the past year.

NKE PE vs Consumer Cyclical Sector

MetricNKESector medianRelative
PE18x18x0.3% above
PE %24745 pts below

NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.

CRWV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$66.615% below
20 week MA$77.427% below
50 week MA$87.435% below

NKE has stronger trend alignment. CRWV is above 0 of 3 weekly averages versus NKE above 1 of 5.

NKE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$36.72.8% above
20 week MA$39.23.6% below
50 week MA$48.021% below
100 week MA$58.435% below
200 week MA$79.252% below

NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.

CRWV Yearly ROI

YearStart priceEnd priceROI
2025$40.0$76.4+91%
2026 YTD$76.4$56.6-26%

CRWV has the edge over NKE on returns for 2026, with the stronger performance.

NKE Yearly ROI

YearStart priceEnd priceROI
2020$101.6$141.6+39%
2021$141.6$165.7+17%
2022$165.7$116.3-30%
2023$116.3$108.6-6.6%
2024$108.6$76.4-30%
2025$76.4$60.9-20%
2026 YTD$60.9$37.8-38%

NKE has finished four years in a row lower, and it's down 38% so far in 2026.

Give your agent the market.

Get API key